Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00059891 | Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer | completed | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00004870 |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer |
| completed |
| Phase 1 / Phase 2 |
| — |
| The University of Texas Health Science Center at San AntonioOTHER |
| 1 |
| Feb 21, 2013 |
| clinicaltrials |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | completed | Phase 2 | 136 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00335595 | Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients | completed | Phase 3 | 480 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00005085 | Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003995 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT01333917 | Curcumin Biomarkers | completed | Phase 1 | 40 | University of North Carolina, Chapel HillOTHER | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00003186 | Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer | completed | N/A | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT01579721 | Prospective Randomized Study of SILS Versus CLS for Rectal Cancer | completed | Phase 4 | 40 | Hvidovre University HospitalOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00005809 | Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia(ACRIN 6656) | completed | N/A | — | American College of Radiology Imaging NetworkNETWORK | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00005864 | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00084721 | Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer | completed | Phase 1 | 2 | Roswell Park Cancer InstituteOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT01778192 | A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate | completed | Phase 3 | 200 | Korea University Anam HospitalOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00444041 | Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer(ASSO-LM1) | completed | Phase 1 / Phase 2 | 43 | Austrian Society Of Surgical OncologyOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT01629524 | Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study) | completed | — | 25 | Yonsei UniversityOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00023933 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 950 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | completed | Phase 3 | 880 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005818 | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00041340 | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00378066 | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | completed | Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00008294 | Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00003360 | Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00077259 | Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | completed | Phase 3 | 2,472 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT01116271 | Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec | completed | Phase 2 | 32 | AstraZenecaINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00039273 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 44 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | completed | Phase 1 / Phase 2 | 51 | University of CologneOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | completed | Phase 3 | 1,135 | SWOG Cancer Research NetworkNETWORK | 4 | Jan 3, 2013 | clinicaltrials |
| NCT00049335 | S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | completed | Phase 3 | 1,158 | NSABP Foundation IncNETWORK | 0 | Jan 3, 2013 | clinicaltrials |
| NCT00597506 | Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus(BEV/EV) | completed | Phase 2 | 50 | Herbert HurwitzOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00027495 | Curcumin for the Prevention of Colon Cancer | completed | Phase 1 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00955188 | Computer-Based Tailored or Standard Information for Colorectal Cancer Screening | completed | — | 345 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00466505 | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 17 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00737646 | Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics | completed | N/A | 5,066 | Centers for Disease Control and PreventionFED | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00994526 | Processed Meat and Colon Carcinogenesis(Hemcancer) | completed | N/A | 18 | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00557102 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung(ERBIFORT) | completed | Phase 2 | 24 | National Cancer Institute, FranceOTHER_GOV | 1 | Dec 11, 2012 | clinicaltrials |
| NCT01243047 | Intermittent Versus Continuous Tarceva Study | completed | Phase 2 | 60 | Chinese University of Hong KongOTHER | 1 | Nov 22, 2012 | clinicaltrials |
| NCT01519609 | Trial Comparing Moviprep and Phosphoral as Bowel Prep Before Colonoscopy | completed | N/A | 400 | Randers Regional HospitalOTHER | 1 | Nov 21, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01483040 | PeerScope B System™ Clinical Protocol | completed | N/A | 50 | PeerMedical Ltd.INDUSTRY | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00375024 | Patient Navigator Project | completed | N/A | 1,267 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 6, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2013source: clinicaltrials